Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Clinical trial NCT03275103 · COMPLETED
Trial details
- NCT number
- NCT03275103
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-19
- Primary completion
- 2026-01-07
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.